These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12426610)

  • 21. Ultrasound for detecting Schistosoma haematobium urinary tract complications: comparison with radiographic procedures.
    Abdel-Wahab MF; Ramzy I; Esmat G; el Kafass H; Strickland GT
    J Urol; 1992 Aug; 148(2 Pt 1):346-50. PubMed ID: 1635130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term suppression of adult bladder morbidity and severe hydronephrosis following selective population chemotherapy for Schistosoma haematobium.
    Subramanian AK; Mungai P; Ouma JH; Magak P; King CH; Mahmoud AA; King CL
    Am J Trop Med Hyg; 1999 Sep; 61(3):476-81. PubMed ID: 10497994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound scanning for detecting morbidity due to Schistosoma haematobium and its resolution following treatment with different doses of praziquantel.
    Hatz C; Mayombana C; de Savigny D; MacPherson CN; Koella JC; Degrémont A; Tanner M
    Trans R Soc Trop Med Hyg; 1990; 84(1):84-8. PubMed ID: 2111949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasonographic urinary tract abnormalities in Schistosoma haematobium infection.
    Salah MA; Böszörményi-Nagy G; Al Absi M; Nagi MA; Alsaaidi AA
    Int Urol Nephrol; 1999; 31(2):163-72. PubMed ID: 10481960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of schistosomiasis in Egypt: Fayoum Governorate.
    Abdel-Wahab MF; Esmat G; Ramzy I; Narooz S; Medhat E; Ibrahim M; El-Boraey Y; Strickland GT
    Am J Trop Med Hyg; 2000 Feb; 62(2 Suppl):55-64. PubMed ID: 10813501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 14-year follow-up of ultrasound-detected urinary tract pathology associated with urogenital schistosomiasis in women living in the Msambweni region of coastal Kenya.
    Joekes E; McMonnies K; Blanshard A; Mutuku FM; Ireri E; Mungai P; Stothard JR; Bustinduy AL; King CH
    Trans R Soc Trop Med Hyg; 2023 Sep; 117(9):637-644. PubMed ID: 37042291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy-based control of schistosomiasis haematobia. II. Metrifonate vs. praziquantel in control of infection-associated morbidity.
    King CH; Lombardi G; Lombardi C; Greenblatt R; Hodder S; Kinyanjui H; Ouma J; Odiambo O; Bryan PJ; Muruka J
    Am J Trop Med Hyg; 1990 Jun; 42(6):587-95. PubMed ID: 2115308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary tract pathology in Schistosoma haematobium infected rural Nigerians.
    Nmorsi OP; Ukwandu NC; Ogoinja S; Blackie HO; Odike MA
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):32-7. PubMed ID: 17539243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morbidity induced by Schistosoma haematobium infections, as assessed by ultrasound before and after treatment with praziquantel, in a recently expanded focus (Senegal River basin).
    Delegue P; Picquet M; Shaw DJ; Vercruysse J; Sambou B; Ly A
    Ann Trop Med Parasitol; 1998 Oct; 92(7):775-83. PubMed ID: 9924535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations.
    King CH; Muchiri EM; Ouma JH
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():203-10. PubMed ID: 1343896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger].
    Garba A; Campagne G; Tassie JM; Barkire A; Vera C; Sellin B; Chippaux JP
    Bull Soc Pathol Exot; 2004 Feb; 97(1):7-11. PubMed ID: 15104149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morbidity assessment in urinary schistosomiasis infection through ultrasonography and measurement of eosinophil cationic protein (ECP) in urine.
    Leutscher PD; Reimert CM; Vennervald BJ; Ravaoalimalala VE; Ramarokoto CE; Serieye J; Raobelison A; Rasendramino M; Christensen NO; Esterre P
    Trop Med Int Health; 2000 Feb; 5(2):88-93. PubMed ID: 10747267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Schistosoma haematobium infection on urinary tract pathology, nutritional status and anaemia in school-aged children in two different endemic areas of the Niger River Basin, Mali.
    Sacko M; Magnussen P; Keita AD; Traoré MS; Landouré A; Doucouré A; Madsen H; Vennervald BJ
    Acta Trop; 2011 Sep; 120 Suppl 1():S142-50. PubMed ID: 21195046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Learning curve of vesico-urinary ultrasonography in Schistosoma haematobium infection with WHO practical guide: a "simple to learn" examination.
    Bonnard P; Boutouaba S; Diakhate I; Seck M; Dompnier JP; Riveau G
    Am J Trop Med Hyg; 2011 Dec; 85(6):1071-4. PubMed ID: 22144446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased ratio of tumor necrosis factor-alpha to interleukin-10 production is associated with Schistosoma haematobium-induced urinary-tract morbidity.
    Wamachi AN; Mayadev JS; Mungai PL; Magak PL; Ouma JH; Magambo JK; Muchiri EM; Koech DK; King CH; King CL
    J Infect Dis; 2004 Dec; 190(11):2020-30. PubMed ID: 15529268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary tract lesions due to Schistosoma haematobium infection assessed by ultrasonography in a community based study in Niger.
    Heurtier Y; Lamothe F; Develoux M; Docquier J; Mouchet F; Sellin E; Sellin B
    Am J Trop Med Hyg; 1986 Nov; 35(6):1163-72. PubMed ID: 3098123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasonographic assessment of urinary tract lesions due to Schistosoma haematobium in Niger after four consecutive years of treatment with praziquantel.
    Laurent C; Lamothe F; Develoux M; Sellin B; Mouchet F
    Trop Med Parasitol; 1990 Jun; 41(2):139-42. PubMed ID: 2116659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya.
    Kahama AI; Odek AE; Kihara RW; Vennervald BJ; Kombe Y; Nkulila T; Hatz CF; Ouma JH; Deelder AM
    Am J Trop Med Hyg; 1999 Aug; 61(2):215-9. PubMed ID: 10463669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversibility of urinary tract abnormalities due to Schistosoma haematobium infection.
    Doehring E; Ehrich JH; Bremer HJ
    Kidney Int; 1986 Oct; 30(4):582-5. PubMed ID: 3097374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morbidity markers for Schistosoma haematobium infection.
    Vennervald BJ; Reimert CM; Ouma JH; Kilama WL; Deelder AM; Hatz C
    Trop Geogr Med; 1994; 46(4 Spec No):239-41. PubMed ID: 7825227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.